美罗华在成人难治性特发性血小板减少性紫癜中的临床应用
被引量:4
摘要
特发性血小板减少性紫癜(idiopathic thrombocytopenic purpura,ITP)是一种器官特异性自身免疫性疾病,在临床上为最常见的出血性疾病。成年ITP年发病率在北美为5.6~20/105〔1〕,欧洲为3.3/105〔2〕,多表现为慢性病程,糖皮质激素治疗对大多数患者有效,但作用短暂。
出处
《临床血液学杂志》
CAS
2010年第6期701-704,共4页
Journal of Clinical Hematology
参考文献31
-
1FOGARTY P F.Chronic immune thrombocytopenia in adults:epidemiology and clinical presentation[J].Hematol Oncol Clin North Am,2009,23:1213-1221. 被引量:1
-
2TERRELL D R,BEEBE L A,VESELY S K,et al.The incidence of immune thrombocytopenic purpura in children and adults:A critical review of published reports[J].Am J Hematol,2010,85:174-180. 被引量:1
-
3KOJOURI K,VESELY S K,TERRELL D R,et al.Splenectomy for adult patients with idiopathic thrombocytopenic purpura:a systematic review to assess long-term platelet count responses,prediction of response,and surgical complications[J].Blood,2004,104:2623-2634. 被引量:1
-
4British Committee for Standards in Heamatology General Haematdogy Task Force.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults,children and in pregnancy[J].Br J Haematol,2003,120:574-596. 被引量:1
-
5TAMARY H,ROGANOVIC J,CHITLUR M,et al.Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia(equb ahead of print)[J].Ann Hematol,2010,Apr 1. 被引量:1
-
6STEVENS W,KOENE H,ZWAGINGA J J,et al.Chronic idiopathic thrombocytopenic purpura:present strategy,guidelines and new insights[J].Neth J Med,2006,64:356-363. 被引量:1
-
7PROVAN D,STASI R,NEWLAND A C,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115:168-186. 被引量:1
-
8GODEAU B.PORCHER R,FAIN O,et al.Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:results of a prospective multicenter phase 2 study[J].Blood,2008,112:999-1004. 被引量:1
-
9COOPER N,STASI R,CUNNINGHAM-RUNDLES S,et al.The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura[J].Br J Haematol,2004,125:232-239. 被引量:1
-
10MEDEOT M,ZAJA F,VIANELLI N,et al.Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura:long-term follow-up results[J].Eur J Haematol,2008,81:165-169. 被引量:1
同被引文献34
-
1Liu B, Zhao H, Poon MC. et al. Abnormality of CD4 + CD25 + regulatory T cell in i - dopathic thromocytope- nic purpura[ J] Eur J Haematol,2007,78(2) :139-43. 被引量:1
-
2Sakakura M, Wada H, Tawara I, et al. Reduced CD4 + CD25 + T cells in patients with idopathic thromocytope- nic purpura [ J ]. Thromb Res, 2007,120 ( 2 ) : 187-93. 被引量:1
-
3Stanglnaier M, Reis S, Hallck M. Rituximab and alemtu- zumab inducc a nonclacc, caspase - independent apop- totic pathway in Blymphoid cell lines and in chronic lymphocytic leukemia cells [ J ]. Ann Hematol, 2004,83 (10) :634-645. 被引量:1
-
4Stasi R, Cooper N, Delpoeta G, et al. Analysis of regula- tory Tcell changes in patients with idopathic thromocyto- penic purpura receiving B cell- deppleting therapy with rituximab(Abstaet) [ J].Blood, 2008,112 (4) : 1147-1150. 被引量:1
-
5Cooper N, Stasi R, Cunninggham - Rundles S, et al. The efficacy and safety of B - cell depletion with anti - CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura [ J ]. Br J Haematol,2004,125 (2) :232-239. 被引量:1
-
6Giagounidis AA, Anhuf J, Schneider P, et al. Treatmentof relapsed idiopathic thrombocytopenic purpura with the anti - CD20 monoclonal antibody rituximab : a pilot study [ J]. Eur J Hae - matol,2002 ,69 :95-100. 被引量:1
-
7Provan D, Butler T, Evangelista ML, et al. Activity and safety profile of low - dose rituximab for the treatment of autoimmune cytopenias in adults [ J ]. Haematologica, 2007,92(12) :1695-1698. 被引量:1
-
8Takeuchi M,Yoshida C,Ota Y,et al.Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura[J].Intern Med,2011,50(12):1339-1343. 被引量:1
-
9Noronha V,Philip SD,Joshi A,et al.Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura[J].Int J Hematol,2012,96(3):380-382. 被引量:1
-
10FrancescoZaja,LucianaMarin,MariannaChiozzotto,SimonaPuglisi,StefanoVolpetti,RenatoFanin.Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab[J]. Am. J. Hematol. . 2012 (3) 被引量:1
引证文献4
-
1陈冬,裴仁治,张丕胜,马俊霞.小剂量利妥昔单抗治疗难治性血小板减少性紫癜的临床研究[J].中国现代医生,2011,49(19):64-66. 被引量:3
-
2万鼎铭,王岩,秦玲.利妥昔单抗治疗难治性免疫性血小板减少症的临床疗效观察[J].医药论坛杂志,2011,32(22):41-42. 被引量:2
-
3赵敏蕾,李琳洁,金炀缙,陈玉,陈延杰.小剂量美罗华联合中药治疗难治性血小板减少性紫癜临床观察[J].辽宁中医杂志,2014,41(6):1176-1177. 被引量:3
-
4王焱,李红,朱传升.不同类型免疫抑制剂治疗原发免疫性血小板减少症疗效比较[J].山东医药,2015,55(11):41-43. 被引量:22
二级引证文献29
-
1贾瑞萍,薛晗,徐宁,赵雪芸,王艺,任秀莲.CD4+ CXCR5+样Tfh细胞在原发免疫性血小板减少症中的表达及意义[J].世界临床医学,2017,11(7):46-47.
-
2马亚妹.利妥昔单抗治疗难治性原发免疫性血小板减少症24例[J].中国药业,2013,22(11):81-82. 被引量:4
-
3阳文捷,林金盈,黄向英,许力,魏华萍.利妥昔单抗在治疗免疫性血小板减少症中的应用[J].重庆医学,2014,43(9):1081-1082. 被引量:9
-
4黎晓鹃,李晓双.ITP患者外周血DC亚群和CD80、CD86表达变化及其与地塞米松治疗效果的相关性分析[J].中国实验血液学杂志,2018,26(6):1752-1756. 被引量:7
-
5陈胜梅,邹典斌.利妥昔单抗治疗成人慢性原发免疫性血小板减少症的临床观察[J].中国处方药,2015,13(10):15-16. 被引量:3
-
6沈静涵,周韶虹.原发免疫性血小板减少症的中医药治疗进展[J].天津药学,2015,27(6):68-69. 被引量:13
-
7蒋从飞,王守华,尤美芹.小剂量美罗华治疗血小板减少症疗效分析[J].中外医学研究,2016,14(7):148-149.
-
8王菱菱,陆米则,陈亨,蒋元强,沈云峰,程枫.重组人血小板生成素联合糖皮质激素治疗免疫性血小板减少症效果观察[J].山东医药,2016,56(22):92-93. 被引量:30
-
9骆林胜,冯爱梅,薛阿利,李强,朱子玲,吴品,张日.小剂量美罗华治疗难治性原发免疫性血小板减少症疗效以及对细胞免疫功能的影响[J].中国医师杂志,2016,18(6):890-891. 被引量:5
-
10张国文.急性肿瘤患者右丙亚胺单药与联合华蟾素注射液治疗对阿霉素所致相关性心脏毒性的影响[J].实用癌症杂志,2016,31(7):1202-1206. 被引量:3
-
1孙国锋,李雪政,陈海林,李书芹,任晓梅.达那唑联合环孢素A治疗成人难治性特发性血小板减少性紫癜20例[J].临床医学,2010,30(5):51-52. 被引量:3
-
2韩海燕,贾国荣.成人难治性特发性血小板减少性紫癜患者采用丙种球蛋白、环孢素、美罗华治疗的有效性[J].临床医药文献电子杂志,2016,3(40):7913-7913. 被引量:1
-
3Mamoharan A,秘营昌.成人难治性特发性血小板减少性紫癜的治疗[J].国外医学(输血及血液学分册),1992,15(4):215-216. 被引量:1
-
4魏之苹.成人难治性特发性血小板减少性紫癜的治疗[J].新医学,1994,25(12):657-659.
-
5梁敏,田娟.达那唑联合长春新碱治疗成人难治性特发性血小板减少性紫癜临床观察[J].海南医学,2011,22(1):40-41. 被引量:4
-
6杨小英.丙种球蛋白治疗成人难治性特发性血小板减少性紫癜32例[J].广东医学院学报,2002,20(4):304-304. 被引量:4
-
7智峰,白晓川.成人难治性特发性血小板减少性紫癜22例临床分析[J].宁夏医科大学学报,2010,32(2):266-267.
-
8李志勇.达那唑联合长春新碱治疗成人难治性特发性血小板减少性紫癜临床研究[J].医学信息(下旬刊),2011,24(9):135-136.
-
9杨国元,唐锦治.成人难治性特发性血小板减少性紫癜的治疗[J].临床内科杂志,1993,10(4):16-17. 被引量:2
-
10韩智娟.成人难治性特发性血小板减少性紫癜治疗进展[J].实用医学杂志,2002,18(2):207-208.